glp 1 and ddp4 combination Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic PDF] Effects Of GLP-1 Analogues,

They work on several pathways linked to how we handle glucose, control hunger, and burn energy

So the fact that healthcare and nutrition professionals have a new therapeutic technique in the holster for these individuals is big news

The dual-pathway activation can intensify appetite suppression, and some patients report stronger gastric symptoms, particularly in the first two weeks

2011 Feb 15;589(Pt 4):963-73.

We were interested in evaluating for possible adverse effects of MT-II including anxiety-like and repetitive behavior, in particular over a subacute period on the order days as opposed to acute treatment on the order of hours as in previous reports [45]